• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Long-Term Outcomes of Laparoscopic Fundoplication for Gastroesophageal Reflux Disease in Japanese Patients

Long-Term Outcomes of Laparoscopic Fundoplication for Gastroesophageal Reflux Disease in Japanese Patients

Fumiaki Yano, MD FACS, Nobuo Omura, MD, Kazuto Tsuboi, MD, Masato Hoshino, MD, Yoshio Ishibashi, MD, Katsunori Nishikawa, MD, Yuichiro Tanaka, MD, Hideyuki Kashiwagi, MD, Katsuhiko Yanaga, MD FACS. Department of Surgery, Jikei University School of Medicine, Tokyo, Japan

Introduction: The laparoscopic fundoplication (LF) is an accepted surgical treatment for gastroesophageal reflux disease (GERD). However, since the number of surgeries in Japan is much lower than that of in western countries, reports on the long-term outcomes of surgical treatment are limited. In this study, long-term outcomes of LF for GERD at a single institution in Japan were evaluated.
Methods: Two-hundred and seventy-six patients underwent surgical treatment of LF for GERD to date. Among them, 42 patients were followed-up for more than 10 years were studied. There were 24 men (57%) and 18 women (43%). Their mean age was 51.3 (range, 18-81) years. Their clinical data collected in a prospectively fashion was retrospectively reviewed. Long-term outcomes were assessed in terms of operative procedure, peri- and postoperative complications, and recurrence rate after surgery. Recurrence was defined as postoperative recurrence of erosive esophagitis and/or evident hiatal hernia.
Results: No operative mortality occurred. The mean follow-up was 133.4 (range 121-171) months. Nissen procedure was performed for 24 patients (57%) and the others (43%) underwent Toupet procedure. A total of 7 perioperative complications were observed in 7 patients (17%), consisting of bleeding mainly from the spleen (12%), and injuries of the esophagus (2.5%) or stomach (2.5%), but no one required conversion to open surgery. Five patients (12%) complained moderate to severe postoperative dysphagia and one patient (2%) required re-do surgery (Nissen to Toupet). Recurrence was diagnosed in 7 patients (17%), and 2 of them (5%) required re-do surgery. The other 5 patients (12%) were treatable with acid suppressive medications. The mean time to recurrence was 58.9±43.7 months. Two patients each recurred by 2 years, 2 to 5 years, and 5 to 10 years, respectively, while only 1 patient recurred more than 10 years after surgery. As patterns of recurrences, 4 patients had sliding hiatal hernia with erosive esophagitis, 2 patients had paraesophageal hiatal hernia, and 1 patient had a disrupted fundoplication.
Conclusion: Long-term non recurrence rate of LF were 83%. LF is a safe and secure procedure for treatment of GERD.


Session: Poster
Program Number: P258
View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals